ArticleMolecular biology reports2020

A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status.

Dania Vázquez-Blomquist et al.PubMed ↗Publisher ↗

No numbers read from the abstract.